No Data
No Data
SomnoMed Pays Loan From Epsilon Direct Lending; Shares Rise 5%
SomnoMed (ASX:SOM) has used a portion of proceeds from its AU$11.5 million entitlement offer to pay a loan from Epsilon Direct Lending, according to a Monday Australian bourse filing. Shares in the sl
SomnoMed Price Target Cut 49% to A$0.23/Share by Wilsons
SomnoMed Price Target Cut 49% to A$0.23/Share by Wilsons
SomnoMed Completes AU$16.8 Million Retail Entitlement Offer
SomnoMed (ASX:SOM) raised AU$16.8 million by completing the retail component of its fully underwritten accelerated non-renounceable entitlement offer, according to a Friday filing with the Australian
Somnomed Raises AU$5.8 Million in Institutional Entitlement Offer; AU$16.8 Million Retail Component to Launch April 16
Somnomed (ASX:SOM) has completed the institutional component of its 1-for-1.01 accelerated non-renounceable entitlement offer of new fully paid shares to raise about AU$5.8 million at AU$0.21 per new
SomnoMed Lowers Earnings, Revenue Guidance for Fiscal 2024; to Launch AU$22.6 Million Entitlement Offer
SomnoMed (ASX:SOM) lowered its earnings and revenue guidance for fiscal 2024 amid manufacturing challenges, according to a Tuesday filing with the Australian Securities Exchange. Revenue is now expect
Somnomed Requests Voluntary Share Suspension Continuation
Somnomed (ASX:SOM) has requested a continuation of its current voluntary share suspension while it prepares a proposed equity capital raising, according to a Friday Australian bourse filing. The medic
No Data